Boosting the Power of Dendritic Cancer Vaccines
The Bio Report - En podcast af Levine Media Group - Onsdage
Kategorier:
Jay Hartenbach, chief operating officer of Diakonos Oncology, discusses the company’s dendritic cell cancer vaccine technology, how it works, and why its lead indication is an aggressive form of brain cancer.
